REBEL Cast Ep86: Baloxavir for Influenza Prophylaxis - a podcast by Salim R. Rezaie, MD

from 2020-09-17T12:00:14

:: ::

Background: Baloxavir (trade name Xofluza) was approved for the treatment of acute, uncomplicated influenza in patients > 12 years of age in October 2018. However, high-quality data has been underwhelming at best for its efficacy in treatment. Back in November of 2018, REBEL EM concluded: Clinical Take Home Point: Consistent with every other study on anti-viral ... Read more